febuxostat has been researched along with oxypurinol in 6 studies
| Studies (febuxostat) | Trials (febuxostat) | Recent Studies (post-2010) (febuxostat) | Studies (oxypurinol) | Trials (oxypurinol) | Recent Studies (post-2010) (oxypurinol) |
|---|---|---|---|---|---|
| 818 | 133 | 710 | 457 | 45 | 83 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Hille, R; Pauff, JM | 1 |
| Finley, JM | 1 |
| Freeman, BA; Hundley, NJ; Kelley, EE; Malik, UZ; Radi, R; Romero, G; Tarpey, MM | 1 |
| Hosoya, T; Iwao, O; Ohno, I; Tatsuo, H | 1 |
| Chang, JY; Chin, SW; Chu, MT; Chung, WH; Huang, YL; Hung, SI; Pan, RY; Wang, WC | 1 |
| Afsar, B; Cherney, D; Covic, A; Dincer, N; Erden, N; Kanbay, M; Kuwabara, M; Ortiz, A; Rossignol, P; Sag, AA; Siriopol, D; Yilmaz, O | 1 |
1 review(s) available for febuxostat and oxypurinol
| Article | Year |
|---|---|
Effect of Uric Acid-Lowering Agents on Cardiovascular Outcome in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Clinical Studies.
Topics: Allopurinol; Enzyme Inhibitors; Febuxostat; Heart Failure; Humans; Oxypurinol; Uric Acid; Xanthine Oxidase | 2020 |
1 trial(s) available for febuxostat and oxypurinol
| Article | Year |
|---|---|
A repeated oral administration study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with impaired renal function in Japan: pharmacokinetic and pharmacodynamic study.
Topics: Administration, Oral; Adult; Aged; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Febuxostat; Female; Follow-Up Studies; Glomerular Filtration Rate; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Oxypurinol; Renal Insufficiency; Thiazoles; Treatment Outcome; Uric Acid; Xanthine Oxidase; Young Adult | 2011 |
4 other study(ies) available for febuxostat and oxypurinol
| Article | Year |
|---|---|
X-ray crystal structure of a xanthine oxidase complex with the flavonoid inhibitor quercetin.
Topics: Animals; Antioxidants; Catalytic Domain; Cattle; Crystallography, X-Ray; Drug Design; Enzyme Inhibitors; Humans; Molecular Conformation; Molecular Structure; Molybdenum; Phenylalanine; Quercetin; Structure-Activity Relationship; Uric Acid; Xanthine; Xanthine Oxidase | 2014 |
Case 8: initiation of urate-lowering therapy for standard advanced gout.
Topics: Arthritis, Gouty; Febuxostat; Humans; Male; Middle Aged; Oxypurinol; Thiazoles; Uric Acid; Uricosuric Agents | 2006 |
Febuxostat inhibition of endothelial-bound XO: implications for targeting vascular ROS production.
Topics: Allopurinol; Animals; Cattle; Cells, Cultured; Endothelial Cells; Enzyme Inhibitors; Febuxostat; Glycosaminoglycans; Kinetics; Oxypurinol; Reactive Oxygen Species; Thiazoles; Xanthine Oxidase | 2011 |
Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Antigens, Differentiation, T-Lymphocyte; Case-Control Studies; Cells, Cultured; Cross Reactions; Drug Eruptions; Enzyme-Linked Immunosorbent Assay; Febuxostat; Female; Humans; Interferon-gamma; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Oxypurinol; Reference Values; Stevens-Johnson Syndrome; Thiazoles | 2015 |